开云网页登录_开云app官网入口下载苹果版

Abstract

CLC Number:

R541.4

Figures/Tables3

疾病	1990年		2016年
疾病	死亡例数（n）	年龄标化死亡率（/10万）	死亡例数（n）	年龄标化死亡率（/10万）
心血管疾病
中国	2 245 278	332.3	4 344 334	268.1
美国	875 094	256.1	880 574	150.5
西欧国家	1 658 229	271.5	1 341 334	122.3
缺血性心脏病
中国	580 578	88.9	1 735746	109.7
美国	605 597	176.9	520 595	88.4
西欧国家	939 500	153.8	656 552	60.7
脑卒中
中国	1 267 953	184.2	2 098 212	125.5
美国	145 028	42.0	168 049	28.5
西欧国家	451 247	73.2	326 258	29.2

References27

[1]	Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action[J]. J Am Coll Cardiol, 2020,76(25):2980-2981. doi:10.1016/j.jacc.2020.11.021 URL
[2]	GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020, 396(10258):1204-1222. doi:10.1016/S0140-6736(20)30925-9 URL
[3]	GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disea-se Study 2019[J]. Lancet,2020, 396(10258):1223-1249. doi:10.1016/S0140-6736(20)30752-2 URL
[4]	Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol,2020, 76(25):2982-3021. doi:10.1016/j.jacc.2020.11.010 URL
[5]	Vekemans J, Gouvea-Reis F, Kim JH, et al. The path to group aStreptococcusVaccines: World Health Organization research and development technology roadmap and preferred product characteristics[J]. Clin Infect Dis, 2019,69(5):877-883. doi:10.1093/cid/ciy1143pmid:30624673
[6]	Yu K, Lv J, Qiu G, et al. Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study[J]. Lancet Glob Health, 2020,8(3):e430-e439.
[7]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021,36(6):521-545.
[8]	Moran A, Zhao D, Gu D, et al. The future impact of popu-lation growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Po-licy Model-China[J]. BMC Public Health, 2008,8:394. doi:10.1186/1471-2458-8-394 URL
[9]	Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC International[J]. J Am Coll Cardiol, 2019,73(24):3135-3147. doi:10.1016/j.jacc.2019.04.036 URL
[10]	Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications[J]. Nat Rev Cardiol, 2019,16(4):203-212. doi:10.1038/s41569-018-0119-4 URL
[11]	Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013,381(9882):1987-2015. doi:10.1016/S0140-6736(13)61097-1 URL
[12]	Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019,394(10204):1145-1158. doi:10.1016/S0140-6736(19)30427-1 URL
[13]	Zhao D. Epidemiological features of cardiovascular di-sease in Asia[J]. JACC: Asia, 2021,1(1):1-13. doi:10.1016/j.jacasi.2021.04.007 URL
[14]	李镒冲, 刘世炜, 曾新颖, 等. 1990-2016年中国及省级行政区心血管病疾病负担报告[J]. 中国循环杂志, 2019,34(8):729-740.
[15]	Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global Burden of disease study[J]. JAMA Cardiol, 2019,4(4):342-352. doi:10.1001/jamacardio.2019.0295 URL
[16]	王文, 朱曼璐, 王拥军, 等. 《中国心血管病报告2012》概要[J]. 中国循环杂志, 2013,28(6):408-412.
[17]	Jiang B, Wang WZ, Chen H, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities[J]. Stroke, 2006,37(1):63-68. pmid:16306469
[18]	Zhang G, Yu C, Zhou M, et al. Burden of ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study[J]. BMC Cardiovasc Disord,2018, 18(1):18. doi:10.1186/s12872-018-0761-0 URL
[19]	Dai H, Much AA, Maor E, et al. Global, regional, and national burden of ischemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020:qcaa076.
[20]	Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet Glob Health, 2013,1(5):e259-e281.
[21]	GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med,2018, 379(25):2429-2437. doi:10.1056/NEJMoa1804492 URL
[22]	Li H, Ge J. Cardiovascular diseases in China: current status and future perspectives[J]. Int J Cardiol Heart Vasc, 2014,6:25-31.
[23]	GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019[J]. Lancet,2021, 397(10292):2337-2360. doi:10.1016/S0140-6736(21)01169-7 URL
[24]	Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults[J]. Int J Cardiol, 2018,260:196-203. doi:S0167-5273(17)32606-2pmid:29622441
[25]	Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000[J]. N Engl J Med, 2007,356(23):2388-2398. doi:10.1056/NEJMsa053935 URL
[26]	Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000[J]. Circulation,2004, 109(9):1101-1107. doi:10.1161/01.CIR.0000118498.35499.B2 URL
[27]	Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J]. J Am Coll Cardiol, 2017,69(9):1116-1125.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables3

References27

Related Articles10

Recommended Articles

Metrics

Comments

[1]	.[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(03): 239-244.
[2]	SHENG Hong, ZHANG Andi.Study on application of nutritional risk screening in hospitalized patients with chronic heart failure[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 178-183.
[3]	WU Jie, FENG Yuanyuan, REN Yan, CAO Jiumei.Survey of risk factors of coronary heart disease in elderly patients with coronary angiography and establishment of relevant diagnostic model[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 201-206.
[4]	ZHA Qing, YU Chenxi, LIU Ya, YANG Ling, YE Jiawen, LIU Yan.Preliminary study on the role of miR-16 in progression of coronary atherosclerosis and possible molecular mechanism[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(01): 82-87.
[5]	LIU Shengjun, LIU Lili, ZHU Zhengbin, SUN Yi, ZHU Tianqi, FENG Shuo, CHEN Xin, QUAN Weiwei, ZHANG Ruiyan.Correlation of estimated glomerular filtration rate with incidence of in-stent restenosis in patients with drug-elu-ting stent[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 297-302.
[6]	LIU Shanshan, Niu Jingya, WANG Tiange, LI Mian, ZHAO Zhiyun, XU Yu, LU Jieli, XU Min, BI Yufang, ZHANG Di.Epidemiological investigation on cardiometabolic abnormalities in Songnan Community residents with type 2 diabetes[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 323-328.
[7]	.[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 237-240.
[8]	HUANG Xiaoyi, CAI Wei, SHU Shizhen, PANG Xiaofen.Correlation of glycosylated hemoglobin and fasting blood glucose level with severity of lesion in elderly patients with carotid artery atherosclerosis[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 82-85.
[9]	.[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 664-667.
[10]	LING Yuan, WANG Shuhong, LIANG Wei, SHEN Linhui.Study on correlation of serum level of C1q tumor necrosis factor-related protein 1（CTRP1) with coronary atherosclerotic heart disease[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(02): 199-203.